SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004376
Filing Date
2021-11-12
Accepted
2021-11-12 16:06:47
Documents
91
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fmtx-20210930.htm   iXBRL 10-Q 4177021
2 EX-31.1 fmtx-ex31_1.htm EX-31.1 11766
3 EX-31.2 fmtx-ex31_2.htm EX-31.2 11938
4 EX-32.1 fmtx-ex32_1.htm EX-32.1 9584
  Complete submission text file 0000950170-21-004376.txt   12690574

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fmtx-20210930_cal.xml EX-101.CAL 60786
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fmtx-20210930_pre.xml EX-101.PRE 423801
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fmtx-20210930_def.xml EX-101.DEF 250488
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fmtx-20210930.xsd EX-101.SCH 76221
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fmtx-20210930_lab.xml EX-101.LAB 549722
10 EXTRACTED XBRL INSTANCE DOCUMENT fmtx-20210930_htm.xml XML 2401002
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39333 | Film No.: 211403434
SIC: 2836 Biological Products, (No Diagnostic Substances)